Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients

Anaesthesia and Intensive Care

Volumn 37, Issue 6, 2009, Pages 944-952

  Jones, T E ^a   Peter, J V ^a,b   Field, J ^a,c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Aminoglycosides; Cockroft Gault; Creatinine clearance; Cystatin C; Gentamicin; Glomerular filtration rate; Intensive care patients; MDRD

Indexed keywords

AMINOGLYCOSIDE; CREATININE; CYSTATIN C; GENTAMICIN; TOBRAMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE;

EID: 74049085435     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0903700611     Document Type: Article

References (35)

1. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
2. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
3. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine. (Abstract). J Am Soc Nephrol 2000; 11:A0828.
4. Reidenberg MM. Kidney function and drug action. N Engl J Med 1985; 313:816-818.
5. le Riche M, Zemlin AE, Erasmus RT, Davids MR. An audit of 24-hour creatinine clearance measurements at Tygerberg Hospital and comparison with prediction equations. S Afr Med J 2007; 97:968-970.
6. Robert S, Zarowitz BJ, Peterson EL, Dumler F. Predictability of creatinine clearance estimates in critically ill patients. Crit Care Med 1993; 21:1487-1495.
7. Wilson RF, Soullier G. The validity of two-hour creatinine clearance studies in critically ill patients. Crit Care Med 1980; 8:281-284.
8. Cherry RA, Eachempati SR, Hydo L, Barie PS. Accuracy of short-duration creatinine clearance determinations in predicting 24-hour creatinine clearance in critically ill and injured patients. J Trauma 2002; 53:267-271.
9. Zarowitz BJ, Robert S, Peterson EL. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann Pharmacother 1992; 26:1205-1210.
10. Pesola GR, Akhavan I, Madu A, Shah NK, Carlon GC. Prediction equation estimates of creatinine clearance in the intensive care unit. Intensive Care Med 1993; 19:39-43.
11. L im WH, McDonald S. Lean body mass-adjusted Cockroft and Gault formula improves the estimation of glomerular filtration rate in subjects with normal-range serum creatinine. Nephrology 2006; 11:250-256.
12. Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med 2002; 28:936-942.
13. Mathew TH, Johnson DW, Jones GRD; Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007; 187:459-463.
14. Mathew TH; Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005; 183:138-141.
15. Du Bois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Int Med 1916; 1:863-871.
16. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR - history, indications, and future research. Clin Biochem 2005; 38:1-8.
17. Grubb A, Nyman U, Bjork J, Lindstrom V, Rippe B, Sterner G et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005; 51:1420-1431.
18. Herget-Rosenthal S, Bokenkamp A, Hofman W. How to estimate GFR-serum creatinine, serum cystatin C or equations. Clin Biochem 2007; 40:153-161.
19. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65:1416-1421.
20. Deeter RG, Krauss EA, Penn F, Nahaczewski AE. Comparison of aminoglycoside clearance and calculated serum creatinine clearances. Ther Drug Monit 1989; 11:155-161.
21. Nakahiro RK, Okamoto MP, Chin A, Gill MA, Chae JS, Sclar DA. Use of gentamicin clearance in estimating renal function. Clin Pharm 1992; 10:931-934.
22. Hickling KG, Begg EJ, Perry RE, Atkinson HC, Sharman JR. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Crit Care Med 1991; 19:1041-1047.
23. Larsson A, Malm J, Grubb A, Hansson LO . Calculation of glomerular filtration rate expressed in mlL/min from plasma cystatin C values in mg/l. Scand J Clin Lab Invest 2004; 64:25-30.
24. Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002; 13:2140-2144.
25. Mariat C, Alamartine E, Barthelemy J-C, De Filippis J-P, Thibaudin D, Berthoux P et al. Assessing renal graft function in clinical trials: can tests predicting glomerular filtration rate substitute for a reference method? Kidney Int 2004; 65:289-297.
26. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003; 14:2573-2580.
27. Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C et al. Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. Am J Kidney Dis 1998; 32:32-42.
28. Hassan E, Ober JD. Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients. Antimicrob Agents Chemother 1987; 31:1855-1858.
29. Mann HJ, Fuhs DW, Awang R, Ndemo FA, Cerra FB. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm 1987; 6:148-153.
30. Dorman T, Swoboda S, Zarfeshenfard F, Trentler B, Lipsett PA. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group. Surgery 1998; 124:73-78.
31. Beckhouse MJ, Whyte IM, Byth PL, Napier JC, Smith AJ. Altered aminoglycoside pharmacokinetics in the critically ill. Anaesth Intensive Care 1989; 16:418-422.
32. Marik PE. Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anaesth Intensive Care 1993; 21:172-173.
33. Demczar DJ, Nafziger AN, Bertino JS Jr. Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing. Antimicrob Agents Chemother 1997; 41:1115-1119.
34. McNamara DR, Nafziger AN, Menhinick AM, Bertino JS Jr. A dose-ranging study of gentamicin pharmacokinetics: implications for extended interval aminoglycoside therapy. J Clin Pharmacol 2001; 41:374-377.
35. Wallace AW, Jones M, Bertino JS. Evaluation of four oncedaily aminoglycoside dosing nomograms. Pharmacotherapy 2002; 22:1077-1083.